Keros Therapeutics, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Keros Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Keros Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $579M, a 77.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$579M	+$253M	+77.6%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$455M	+$98.7M	+27.7%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$486M	+$101M	+26.4%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$370M	+$63.2M	+20.6%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$326M	+$73.7M	+29.2%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$356M	+$130M	+57.2%	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$384M	+$149M	+63.5%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$307M	+$51.5M	+20.2%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$253M	+$22.6M	+9.82%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$227M	-$16.8M	-6.9%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$235M	-$22.6M	-8.76%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$255M	-$14.2M	-5.27%	Dec 31, 2021	10-K	2023-03-03
Q3 2021	$230M	+$91.7M	+66.3%	Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$243M	+$93M	+61.8%	Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$258M	+$197M	+325%	Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$269M	+$258M	+2360%	Dec 31, 2020	10-K	2022-03-09
Q3 2020	$138M			Sep 30, 2020	10-Q	2020-11-10
Q2 2020	$150M			Jun 30, 2020	10-Q	2020-08-13
Q1 2020	$60.6M			Mar 31, 2020	10-Q	2020-05-22
Q4 2019	$11M			Dec 31, 2019	10-K	2021-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.